Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0070
-0.00052 (-6.91%)
At close: Jun 16, 2026
Evofem Biosciences Revenue
Evofem Biosciences had revenue of $899.00K in the quarter ending March 31, 2026, with 6.39% growth. This brings the company's revenue in the last twelve months to $20.24M, up 21.87% year-over-year. In the year 2025, Evofem Biosciences had annual revenue of $20.18M with 4.23% growth.
Revenue (ttm)
20.24M
Revenue Growth
+21.87%
P/S Ratio
0.05
Revenue / Employee
697.83K
Employees
29
Market Cap
996.63K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.18M | 820.00K | 4.23% |
| Dec 31, 2024 | 19.36M | 1.15M | 6.28% |
| Dec 31, 2023 | 18.22M | 1.38M | 8.20% |
| Dec 31, 2022 | 16.84M | 8.59M | 104.23% |
| Dec 31, 2021 | 8.24M | 7.80M | 1,748.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEvofem Biosciences News
- 4 weeks ago - Evofem reports Q1 EPS (4c) vs. 0c last year - TheFly
- 4 weeks ago - Evofem Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - Evofem Biosciences Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Evofem Biosciences Earnings release: Q1 2026 - Filings
- 7 weeks ago - Evofem enters exclusive distribution agreement with Clovis Davis for SOLOSEC - TheFly
- 7 weeks ago - Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa - Business Wire
- 3 months ago - Evofem Reports Fifth Consecutive Year of Net Sales Growth - Business Wire
- 3 months ago - Evofem Biosciences Slides: Investor presentation - Filings